We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
-10.44%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.48B
AUM Growth
-$231M
Cap. Flow
-$20.7M
Cap. Flow %
-1.4%
Top 10 Hldgs %
29.59%
Holding
596
New
70
Increased
138
Reduced
203
Closed
108

Sector Composition

Rank Sector Weight
1 Technology 13.53%
2 Healthcare 6.24%
3 Communication Services 5.22%
4 Financials 5%
5 Industrials 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UVV icon
326
Universal Corp
UVV
$1.31B
$439K 0.03%
8,100
-800
-9% -$51.5K
IBB icon
327
iShares Biotechnology ETF
IBB
$9.35B
$437K 0.03%
4,529
-773
-15% -$82K
RDN icon
328
Radian Group
RDN
$5.07B
$437K 0.03%
26,700
MEDP icon
329
Medpace
MEDP
$17.3B
$434K 0.03%
8,200
-3,500
-30% -$192K
VRS
330
DELISTED
Verso Corporation
VRS
$432K 0.03%
19,300
-9,000
-32% -$243K
SCHM icon
331
Schwab US Mid-Cap ETF
SCHM
$14.7B
$431K 0.03%
26,961
ENVA icon
332
Enova International
ENVA
$5.42B
$428K 0.03%
22,000
+9,200
+72% +$210K
HURC icon
333
Hurco Companies Inc
HURC
$139M
$428K 0.03%
11,992
-2,258
-16% -$90.2K
BMRN icon
334
BioMarin Pharmaceuticals
BMRN
$11.4B
$426K 0.03%
5,000
STLD icon
335
Steel Dynamics
STLD
$34.7B
$424K 0.03%
14,109
+3,844
+37% +$145K
IRT icon
336
Independence Realty Trust
IRT
$3.87B
$421K 0.03%
45,900
-4,300
-9% -$42.4K
KURA icon
337
Kura Oncology
KURA
$928M
$421K 0.03%
30,000
KBR icon
338
KBR
KBR
$4.61B
$420K 0.03%
27,700
SHOO icon
339
Steven Madden
SHOO
$3.08B
$418K 0.03%
+13,800
New +$425K
ESPR
340
DELISTED
Esperion Therapeutics
ESPR
$414K 0.03%
9,000
INTT icon
341
inTEST
INTT
$185M
$413K 0.03%
67,340
-1,180
-2% -$8.08K
PRGS icon
342
Progress Software
PRGS
$1.51B
$412K 0.03%
11,600
-5,100
-31% -$170K
RCKY icon
343
Rocky Brands
RCKY
$302M
$411K 0.03%
15,796
-4,400
-22% -$114K
MATX icon
344
Matsons
MATX
$6.46B
$410K 0.03%
12,800
IBCP icon
345
Independent Bank Corp
IBCP
$755M
$408K 0.03%
19,400
-11,100
-36% -$250K
NHC icon
346
National Healthcare
NHC
$3.46B
$408K 0.03%
5,200
-3,600
-41% -$282K
OFG icon
347
OFG Bancorp
OFG
$2.22B
$408K 0.03%
+24,800
New +$417K
VATE icon
348
INNOVATE Corp
VATE
$115M
$408K 0.03%
+15,460
New +$652K
ACCO icon
349
Acco Brands
ACCO
$362M
$405K 0.03%
59,800
+8,900
+17% +$76.2K
DAN icon
350
Dana Inc
DAN
$2.97B
$402K 0.03%
29,500
-148,428
-83% -$2.25M

Similar funds

Bailard's Q4 2018 Portfolio in Review

As of Q4 2018, Bailard held 596 positions worth $1.48B, down 14% from $1.71B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bailard's Q4 2018 filing shows 70 new, 138 increased, 203 reduced and 108 closed positions. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 513,630 shares worth $56.7M. The largest sale was Invesco QQQ Trust, an estimated $55M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Communication Services.

  • Bailard's largest Q4 2018 buy was iShares 0-1 Year Treasury Bond ETF: 513,630 shares worth $56.7M.
  • Bailard added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q4 2018, an estimated $56.8M increase.
  • Bailard's biggest Q4 2018 reduction was Invesco QQQ Trust, cutting an estimated $55M.
  • Bailard fully exited Reliance Steel & Aluminium in Q4 2018, selling an estimated $2.95M.
  • Bailard's ten largest holdings make up 30% of its $1.48B portfolio in Q4 2018.
  • Bailard opened 70 new positions and closed 108 in Q4 2018.
  • Bailard's portfolio value fell 14% quarter-over-quarter to $1.48B.

Based on Bailard's 13F filing for Q4 2018, filed 5 Feb 2019.